Overview

Global leaflet status across every market Northstar operates in.

Active Medications

126

+4 this quarter

Countries

42

3 launches pending

Pending Updates

18

6 due within 7 days

Leaflets Current

99.8%

Target 99.5%

Global compliance map

Leaflet status by country · demonstration data

CurrentUpdate RequiredPending ApprovalNot Yet Available

Action required

  • Safety language update required for Cardevia in Germany

    BfArM circular 2026/114 · due in 4 days

  • French translation pending approval for Metabrix

    Awaiting local affiliate sign-off · 2 reviewers assigned

  • New recall notice ready to publish

    Respira lot RSP-2291 · 6 markets affected

  • Pharmacy print template requires review

    EU large-print template v3 · accessibility check pending

Open regulatory workflow

Recent activity

  1. Leaflet published

    12 min ago

    Respira v6.0 · 39 markets

  2. Translation approved

    48 min ago

    Novalyn · Norwegian (nb-NO)

  3. Safety warning updated

    2 h ago

    Cardevia · hepatic monitoring

  4. QR code scanned

    3 h ago

    Metabrix · 1,240 scans in the last hour

  5. Pharmacy print request completed

    5 h ago

    Apotheke Mitte, Berlin · 12 copies

  6. Leaflet published

    Yesterday

    Solvexa v1.9 · Portugal